KIF3A and non-small cell lung carcinoma: Kim et al. further showed that KIF3A formed a complex with β-arrestin to inhibit Wnt/β-catenin signalling, and IHC revealed that low KIF3A expression was correlated with higher β-catenin expression and poor prognosis of NSCLC patients [234].